WW International, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Julie J. Rice
- Full Time Employees
- 3,700
- Sector
- Consumer Cyclical
- Industry
- Personal Products & Services
- Address
- 675 Avenue of the Americas New York City NY United States of America 10010
- IPO Date
- Nov 15, 2001
- CIK
- 0000105319
- Website
- corporate.ww.com
- Similar Companies
- Business
- WW International, Inc. (Nasdaq: WW) operates as a global leader in science-backed weight management and wellness services, offering a holistic model that integrates behavioral science, digital tools, clinical interventions, and community support to help members achieve sustainable health goals. Founded in 1963 by Jean Nidetch in Queens, New York, the company is headquartered in New York City and conducts operations primarily in the United States, with additional presence in countries including Canada, the United Kingdom, Germany, Australia, and others across North America, Europe, and select international markets. Its core products and services encompass the proprietary Points program (including PointsPlus, SmartPoints, and PersonalPoints systems), which assigns values to foods based on nutritional content to guide personalized meal planning; digital subscriptions via mobile app and web platform providing interactive tracking, AI-driven customization, recipes, workouts, and zero-point foods like fruits, vegetables, and lean proteins; in-person and virtual workshops led by coaches; clinical programs offering GLP-1 weight-loss medications such as Wegovy (in partnership with Novo Nordisk), telehealth consultations, and support for diabetes management; WeightWatchers-branded merchandise including bars, snacks, cookbooks, and kitchen tools; and employer-focused platforms like WeightWatchers for Business for health plans and payers. The company serves approximately 3.8 million subscribers, targeting individuals seeking weight loss, maintenance, fitness, and mindset improvements, with tailored options for those using medications or addressing specific health needs. Recent major developments include its emergence from Chapter 11 bankruptcy in July 2025 after filing in May, which reduced debt by over $1.15 billion (more than 70%) through a court-confirmed reorganization plan, delisting from Nasdaq temporarily, and swift relisting to strengthen its capital structure; strategic partnerships with Novo Nordisk to expand access to injectable and oral GLP-1 medications like Wegovy, LabCorp, Deutsche Bank, Bosch Health, CheqUp (UK telehealth launched in May 2025 exceeding expectations), Gifthealth, and potential expansions with Eli Lilly, Amazon, and others to enhance medication fulfillment, employer benefits, and international clinical capabilities; a pivot to telehealth and AI-fueled digital health solutions driving subscriber growth to 3.4 million (including 135,000 clinical subscribers) by early 2025 and a stock surge exceeding 3,500%; Q3 2025 earnings reflecting transformation efforts with international executive hires to accelerate abroad growth; and ongoing enhancements like water and vegetable bonuses in PersonalPoints, Headspace meditation integration, and Connect community features.
Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International Q1 Earnings Call Highlights
WW International Logs Lower Sales
Weight Watchers Announces First Quarter 2026 Results
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
Is Eli Lilly (LLY) 34.7% Undervalued After Q1 2026 Beat? EPS $8.26 vs. $7.02 Est.; Revenue $19.80B vs. $17.62B Est.; GF Score 94/100
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect
Weight Watchers Announces Board Committee Appointments
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Weight Watchers Announces Leadership Transition and Board Updates
Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®
WW International, Inc. (WGHTQ) Q4 2025 Earnings Call Transcript
WW International beats fourth quarter estimates on clinical subscription growth
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
WW International, Inc. (NASDAQ:WW) Short Interest Up 28.9% in February